Nitrogen → 4-(3-Phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride salt

HRID 870735노트

반응식

HRID 870735 반응식
[CH:1]([O:4][C:5]([N:7]1[CH2:12][CH2:11][N:10]([C:13]2[CH:14]=[CH:15][C:16]3[N:17]([C:19](Br)=[CH:20][N:21]=3)[N:18]=2)[CH2:9][CH2:8]1)=[O:6])([CH3:3])[CH3:2].[C:23]1(B(O)O)[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1.O.[O-]P([O-])([O-])=O.[K+].[K+].[K+].[Cl:41]CCl.N#N>COCCOC.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].O>[ClH:41].[CH:1]([O:4][C:5]([N:7]1[CH2:12][CH2:11][N:10]([C:13]2[CH:14]=[CH:15][C:16]3[N:17]([C:19]([C:23]4[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=4)=[CH:20][N:21]=3)[N:18]=2)[CH2:9][CH2:8]1)=[O:6])([CH3:3])[CH3:2]

참가 물질

9

반응물 5

HCID 947Nitrogen2회HCID 6344DichloromethaneHCID 66827Phenylboronic AcidHCID 22031701Potassium phosphate, tribasic, monohydrateHCID 86696444HCID 86696444, 화합물

생성물 1

HCID 866964424-(3-Phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride salt수율 384.7%

시약·촉매·용매 3

HCID 178418228Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)촉매HCID 962Water용매HCID 80711,2-Dimethoxyethane용매

반응 조건

온도
85 °C

실험 절차

To a mixture of 4-(3-bromo-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester (330.0 mg, 0.9 mmol), phenyl boronic acid [98-80-8] (131.4 mg, 1.1 mmol), potassium phosphate tribasic monohydrate [27176-10-9] (416.4 mg, 1.8 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), complex with dichloromethane [95464-05-4] (77.1 mg, 0.1 mmol) contained in a 50 mL round bottomed flask was added a solution of 30% (v/v) water in 1,2-dimethoxyethane (25 mL) and a magnetic stir bar. The reaction pot was fitted to a reflux condenser, lowered into an ambient temperature oil bath, and the system taken through 10 evacuation/N2 blanket cycles while being rapidly stirred. The rapidly stirred, N2 blanketed, reaction was heated to an oil bath temperature of 85° C. for 17 h then cooled and partitioned between brine (pH adjusted to 10 with 3N aqueous sodium hydroxide) and ethyl acetate. The phase separated extract was dried (MgSO4) and evaporated to afford an orange oil which was purified by preparative RP-HPLC. Isolated product was dissolved in methanol, diluted with concentrated hydrochloric acid, evaporated to dryness, redissolved in methanol and precipitated by the addition of diethyl ether. Filtration of the precipitate yielded 154.6 mg of 4-(3-phenyl-imidazo[1,2-b]pyridazin-6-yl)-piperazine-1-carboxylic acid isopropyl ester monohydrochloride salt as a white crystalline powder, mp. 232-233° C. (dec). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.22 (d, J=6.32 Hz, 6H) 3.50-3.60 (m, 4H) 3.60-3.70 (m, 4H) 4.77-4.87 (m, 1H) 7.50 (d, J=7.58 Hz, 1H) 7.55-7.71 (m, 2H) 7.77 (d, J=10.11 Hz, 1H) 8.05-8.17 (m, 2H) 8.25 (d, J=10.11 Hz, 1H) 8.54 (s, 1H). 13C NMR (100 MHz, DMSO-d6) δ ppm 21.95, 42.49, 44.98, 68.23, 116.22, 120.94, 122.22, 126.28, 127.18, 128.09, 128.83, 129.05, 132.74, 154.26, 155.80. LRMS (ESI) m/z 366.2 [(M+H)]+, calc'd for C20H23N5O2: 395.44.

후처리

  1. customcontained in a 50 mL round bottomed flask
  2. customThe reaction
  3. custompot was fitted to a reflux condenser
  4. customlowered into an ambient temperature
  5. stirringThe rapidly stirred
  6. customreaction
  7. temperaturethen cooled
  8. custompartitioned between brine (
  9. customThe phase separated
  10. extractionextract
  11. dry with materialwas dried (MgSO4)
  12. customevaporated
  13. customto afford an orange oil which
  14. customwas purified by preparative RP-HPLC
  15. dissolutionIsolated product was dissolved in methanol
  16. additiondiluted with concentrated hydrochloric acid
  17. customevaporated to dryness
  18. dissolutionredissolved in methanol
  19. customprecipitated by the addition of diethyl ether
  20. filtrationFiltration of the precipitate

출처 및 근거

ORD 기록
ord-770b1104b20c4128913aab22c877f4a8
출처 데이터셋
uspto-grants-2015_03
특허 번호
US08969565B2

반응 노트

불러오는 중…